Birdwatch Archive

Birdwatch Note

2024-03-08 04:04:41 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

What Biden states is factually correct. Since the successful application of messenger RNA (mRNA) vaccines in preventing COVID-19... mRNA cancer vaccines have emerged as a promising novel approach to cancer immunotherapy. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511650/#:~:text=Among%20the%20promising%20strategies%20in,and%20normal%20cells%20(13).

Written by B723D8753A381ED9D4FBEB1F59044F9A1965DE30B25A31AF0BCB0A67144940B3
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1765932481478299688

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1765951747430744093
  • noteId - 1765951747430744093
  • participantId -
  • noteAuthorParticipantId - B723D8753A381ED9D4FBEB1F59044F9A1965DE30B25A31AF0BCB0A67144940B3 Participant Details
  • createdAtMillis - 1709870681041
  • tweetId - 1765932481478299688
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • What Biden states is factually correct. Since the successful application of messenger RNA (mRNA) vaccines in preventing COVID-19... mRNA cancer vaccines have emerged as a promising novel approach to cancer immunotherapy. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511650/#:~:text=Among%20the%20promising%20strategies%20in,and%20normal%20cells%20(13).

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-03-08 04:04:41 UTC
(1709870681041)
2024-03-09 21:07:52 UTC
(1710018472578)
CURRENTLY_RATED_HELPFUL 2024-03-10 02:46:15 UTC
(1710038775311)
NEEDS_MORE_RATINGS 2024-03-09 21:07:52 UTC
(1710018472578)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-03-08 05:14:15 -0600 Rating Details
2024-03-08 04:38:27 -0600 Rating Details
2024-03-08 04:14:10 -0600 Rating Details
2024-03-08 04:05:09 -0600 Rating Details
2024-03-08 03:53:49 -0600 Rating Details
2024-03-08 03:51:38 -0600 Rating Details
2024-03-08 03:15:09 -0600 Rating Details
2024-03-08 03:09:45 -0600 Rating Details
2024-03-08 02:44:30 -0600 Rating Details
2024-03-08 01:31:08 -0600 Rating Details
2024-03-08 01:27:39 -0600 Rating Details
2024-03-08 01:22:00 -0600 Rating Details
2024-03-08 01:13:58 -0600 Rating Details
2024-03-08 00:48:22 -0600 Rating Details
2024-03-08 00:31:31 -0600 Rating Details
2024-03-08 00:07:57 -0600 Rating Details
2024-03-08 00:00:45 -0600 Rating Details
2024-03-07 23:37:31 -0600 Rating Details
2024-03-07 23:36:09 -0600 Rating Details
2024-03-07 23:34:03 -0600 Rating Details
2024-03-07 23:12:23 -0600 Rating Details
2024-03-07 23:02:00 -0600 Rating Details
2024-03-07 22:58:13 -0600 Rating Details
2024-03-07 22:26:37 -0600 Rating Details
2024-03-07 22:26:22 -0600 Rating Details
2024-03-07 22:21:32 -0600 Rating Details
2024-03-07 22:19:56 -0600 Rating Details
2024-03-07 22:15:55 -0600 Rating Details
2024-03-08 05:11:52 -0600 Rating Details
2024-03-08 04:31:28 -0600 Rating Details
2024-03-08 03:49:48 -0600 Rating Details
2024-03-08 03:14:32 -0600 Rating Details
2024-03-08 02:59:44 -0600 Rating Details
2024-03-08 02:46:56 -0600 Rating Details
2024-03-08 02:17:12 -0600 Rating Details
2024-03-08 01:46:45 -0600 Rating Details
2024-03-08 01:35:47 -0600 Rating Details
2024-03-08 00:57:13 -0600 Rating Details
2024-03-08 00:55:57 -0600 Rating Details
2024-03-08 00:52:38 -0600 Rating Details
2024-03-08 00:50:51 -0600 Rating Details
2024-03-08 00:20:01 -0600 Rating Details
2024-03-07 23:54:45 -0600 Rating Details
2024-03-07 23:35:39 -0600 Rating Details
2024-03-07 23:27:36 -0600 Rating Details
2024-03-07 23:17:00 -0600 Rating Details
2024-03-07 22:57:43 -0600 Rating Details
2024-03-07 22:46:59 -0600 Rating Details
2024-03-07 22:45:45 -0600 Rating Details
2024-03-07 22:39:16 -0600 Rating Details
2024-03-07 22:28:15 -0600 Rating Details
2024-03-07 22:10:58 -0600 Rating Details
2024-03-08 03:29:57 -0600 Rating Details
2024-03-08 03:24:23 -0600 Rating Details
2024-03-08 03:05:34 -0600 Rating Details
2024-03-08 03:03:35 -0600 Rating Details
2024-03-08 02:57:12 -0600 Rating Details
2024-03-08 02:56:42 -0600 Rating Details
2024-03-08 02:45:06 -0600 Rating Details
2024-03-08 02:17:34 -0600 Rating Details
2024-03-08 02:10:53 -0600 Rating Details
2024-03-08 01:48:02 -0600 Rating Details
2024-03-08 01:34:03 -0600 Rating Details
2024-03-08 01:20:53 -0600 Rating Details
2024-03-08 00:49:29 -0600 Rating Details
2024-03-08 00:28:22 -0600 Rating Details
2024-03-08 00:06:11 -0600 Rating Details
2024-03-07 23:19:01 -0600 Rating Details
2024-03-07 23:18:53 -0600 Rating Details
2024-03-07 23:00:53 -0600 Rating Details
2024-03-07 22:51:51 -0600 Rating Details
2024-03-07 22:49:20 -0600 Rating Details
2024-03-07 22:48:10 -0600 Rating Details
2024-03-07 22:47:44 -0600 Rating Details
2024-03-07 22:25:46 -0600 Rating Details
2024-03-07 22:25:12 -0600 Rating Details
2024-03-07 22:22:07 -0600 Rating Details
2024-03-07 22:19:43 -0600 Rating Details
2024-03-07 22:18:11 -0600 Rating Details